Just took a look at Pfizer's earning yesterday. When they first introduced Paxlovid their MC went up by about $50 billion or about 2X's expected sales. Their MC has come down about half of where it peeked at so in round about numbers the MC is up about 1X's annual expected sales of Paxlovid of $22 billion.

It sure would be nice for us to have positive COVID results from the trial that we are currently in. It would be doubly nice as we have such a clean safety profile from our previous trials.

tada